SCHEMBL29840719

SCHEMBL29840719

O=C(Nc1cccc(Cl)c1)C1CC(F)CN1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.50
▸ KMT2A Q03164 6/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ HTT P42858 4/20 0.49
▸ LMNA P02545 4/20 0.49
▸ MAPT P10636 3/20 0.49
▸ KDM4E B2RXH2 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ F13A1 P00488 1/20 0.47
▸ TGM2 P21980 1/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ EPHX1 P07099 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ EPHX2 P34913 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18591149 1.00 MEN1 (0.50) MEN1KMT2AALDH1A1SMN1; SMN2HTT
Hydrochloric Acid SCHEMBL18578488 0.99 MEN1 (0.49) MEN1KMT2AALDH1A1SMN1; SMN2HTT
SCHEMBL18591145 0.84 GRK2 (0.49) MEN1KMT2ALMNATGM2RAB9A
SCHEMBL29545839 0.84 GRK2 (0.49) MEN1KMT2ALMNATGM2RAB9A
SCHEMBL30945059 0.83 DPP4 (0.54) MEN1KMT2ASMN1; SMN2MAPTHPGD
Hydrochloric Acid SCHEMBL18554739 0.83 GRK2 (0.48) MEN1KMT2ASMN1; SMN2LMNATGM2
SCHEMBL20296977 0.82 EPHX2 (0.44) NPSR1EPHX2
SCHEMBL18555058 0.79 CTSC (0.40) MEN1KMT2ASMN1; SMN2HTTLMNA
SCHEMBL29840717 0.79 CTSC (0.40) MEN1KMT2ASMN1; SMN2HTTLMNA
Hydrochloric Acid SCHEMBL18578638 0.78 CTSC (0.39) MEN1KMT2ASMN1; SMN2HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4053117-A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS Achillion Pharmaceuticals, Inc. (US) 2022-09-07 — — EP claimed
EP-3340981-B1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS ACHILLION PHARMACEUTICALS INC (US) 2022-10-12 — — EP disclosed
EP-4053117-A1 ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS Achillion Pharmaceuticals, Inc. (US) 2022-09-07 — — EP disclosed
Send feedback